Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01108068 · ClinicalTrials.gov registry record · NA
Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01108068 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 26 participants.
The verdict
NCT01108068, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This was a pilot study of 10 patients with Osteoporosis-pseudoglioma syndrome (OPPG) from the Old Order Mennonite community and 16 controls, who did not have OPPG. Five of the 10 OPPG patient elected to participate in the Lithium trial and 5 participated only in baseline data (labs, pQCT). The 5 with OPPG who were given lithium for 6 months had both dual energy xray absorptiometry (DXA), peripheral quantitative computerized tomography (pQCT) and lab assessment at baseline and 6 months. Studies in the mouse model of OPPG showed that lithium normalized their bone strength. Controls (n=16) were recruited from the Old Order Mennonite community, to minimize the effects of environmental and lifestyle factors. The controls were not be given lithium. The age range of participants was 4-64 years.
Interventions
- DRUG Lithium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01108068
The ClinicalTrials.gov registry entry for NCT01108068 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lithium is the first listed.
NCT01108068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01108068 about?
NCT01108068 is a clinical study titled "Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome". This was a pilot study of 10 patients with Osteoporosis-pseudoglioma syndrome (OPPG) from the Old Order Mennonite community and 16 controls, who did not have OPPG. Five of the 10 OPPG patient elected to participate in the Lithium trial and 5 participated only in baseline data (labs, pQCT). The 5 wit...
What is the current status of trial NCT01108068?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2010-07. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01108068?
The interventions under investigation include: Lithium (DRUG).
Who is sponsoring clinical trial NCT01108068?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.